Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-8.85M
↓ 120% below average
Average (4y)
$-4.03M
Historical baseline
Range
High:$-733693.00
Low:$-8.85M
CAGR
+86.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-8.85M | -21.0% |
| 2023 | $-7.31M | -365.8% |
| 2022 | $-1.57M | +6.9% |
| 2021 | $-1.69M | -129.7% |
| 2020 | $-733693.00 | - |